Low regulatory T-cells frequency is associated with graft rejection after small bowel transplantation: Clinical and experimental evidence
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0307534 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Rodrigo Papa-Gobbi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Immunological and Pathophysiological Studies (IIFP), School of Exact Sciences, National University of La Plata, National Council of Sci…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Graft Rejection, Intestine, Small. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Transplantation Society, Fundación Mutua Madrileña, Instituto de Salud Carlos III.
Abstract (Originalsprache)
Background
Intestinal transplantation (ITx) represents the only curative option for patients with irreversible intestinal failure. Nevertheless, its rejection rate surpasses that of other solid organ transplants due to the heightened immunological load of the gut. Regulatory T-cells (Tregs) are key players in the induction and maintenance of peripheral tolerance, suggesting their potential involvement in modulating host vs . graft responses after ITx. Thus, we investigated the association of Tregs with allograft outcomes in pediatric patients and in an experimental model of small bowel transplantation.
Methods
Treg frequency in human samples was analyzed by Flow cytometry (CD4 + CD25 high CD127 - , blood samples) and immunohistochemistry (FoxP3, graft samples). Experimental allogenic-heterotopic small bowel transplantation was performed in rats and animals divided into 3 groups: non-immunosuppressant treatment, rapamycin (2 mg/kg), and tacrolimus (0.6 mg/kg) treatment. Acute cellular rejection (ACR) was diagnosed based on clinical and histological findings, graft gene expression of pro- and anti-inflammatory mediators assessed by RT-qPCR, serum IL-6 and IL-10 levels by Luminex, and Treg frequency analyzed by flow cytometry (CD4 + CD25 high FoxP3 + ).
Results
Blood samples from patients undergoing ACR exhibited a significant reduction in the Treg number compared to those with normo-functional grafts. Similarly, a diminished number of FoxP3 + cells was observed in mucosa samples with ACR. In the experimental model, rapamycin-treated animals displayed clinical and histological findings resembling those not receiving immunosuppression treatment. Notably, ACR correlated with a high CD8/CD4 ratio, loss of T-cell chimerism, mRNA upregulation of pro-inflammatory genes and diminished graft Treg frequency. In contrast, tacrolimus treatment prevented ACR and facilitate blood and graft Treg expansion. Remarkably, recipients who achieved Treg expansion within the graft remained free of ACR even after discontinuation of the immunosuppressant treatment and this phenomenon was associated with increased levels of serum IL-10.
Conclusion
Our clinical and experimental findings underscore the association between Treg frequency and graft rejection after ITx, advocating for strategies that promote their expansion within the gut mucosa to enhance long-term outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Immunological and Pathophysiological Studies (IIFP), School of Exact Sciences, National University of La Plata, National Council of Scientific and Technical Research (CONICET), La Plata, Argentina.
- Intestinal Failure, Rehabilitation and Transplant Unit, University Hospital Foundation Favaloro; Institute of Translational Medicine, Transplantation and Bioengineering (ImeTTyB), University Favaloro-CONICET, Buenos Air…
- Special Pathology Laboratory, Faculty of Veterinary Sciences, National University of La Plata, La Plata, Buenos Aires, Argentina.
- Transplant Group, La Paz University Hospital Health Research Institute (IdiPAZ), Madrid, Spain.
- Department of Pediatric Surgery, La Paz University Hospital, Madrid, Spain.
- Immunology Department, 12 de Octubre University Hospital, Madrid, Spain.
ORCID-Profile: Rodrigo Papa-Gobbi
Förderung
- Transplantation Society
- Fundación Mutua Madrileña
- Instituto de Salud Carlos III
Zitieren
APA
Papa-Gobbi, R., Stringa, P., Gentilini, M. V., Ivanoff, I., Machuca, M., Arreola, N. M., Serradilla, J., Estefanía-Fernández, K., Talayero, P., Velayos, M., Sánchez-Zapardiel, E., Gondolesi, G., Andrés-Moreno, A., Rumbo, M., & Hernández-Oliveros, F. (2025). Low regulatory T-cells frequency is associated with graft rejection after small bowel transplantation: Clinical and experimental evidence. PLOS ONE. https://doi.org/10.1371/journal.pone.0307534
Vancouver
Papa-Gobbi R, Stringa P, Gentilini MV, Ivanoff I, Machuca M, Arreola NM, et al. Low regulatory T-cells frequency is associated with graft rejection after small bowel transplantation: Clinical and experimental evidence. PLOS ONE. 2025. doi:10.1371/journal.pone.0307534
BibTeX
@article{PapaGobbi2025,
author = {Papa-Gobbi, Rodrigo and Stringa, Pablo and Gentilini, Maria Virginia and Ivanoff, Ivana and Machuca, Mariana and Arreola, Nidia Monserrat and Serradilla, Javier and Estefanía-Fernández, Karla and Talayero, Paloma and Velayos, María and Sánchez-Zapardiel, Elena and Gondolesi, Gabriel and Andrés-Moreno, Ane and Rumbo, Martin and Hernández-Oliveros, Francisco},
title = {Low regulatory T-cells frequency is associated with graft rejection after small bowel transplantation: Clinical and experimental evidence},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0307534}
}
EUVIMED